From the Department of Neurology (A.K., R.B.), Department of Cardiology (G.S.), Centre for Integrated Medicine and Research (CIMR) (D.D.), and Department of Biostatistics (S.V.), All India Institute of Medical Sciences (R.K.S., D.D., M.T., M.V.P.S.); and Cardio-thoracic Centre (G.S.), New Delhi, India.
Neurology. 2020 May 26;94(21):e2203-e2212. doi: 10.1212/WNL.0000000000009473. Epub 2020 May 6.
To evaluate the effectiveness of yoga as an adjuvant to conventional medical management on clinical outcomes in patients with migraine.
CONTAIN was a prospective, randomized, open-label superiority trial with blinded endpoint assessment carried out at a single tertiary care academic hospital in New Delhi, India. Patients enrolled were aged 18-50 years with a diagnosis of episodic migraine and were randomized into medical and yoga groups (1:1). Randomization was computer-generated with a variable block size and concealed. A predesigned yoga intervention was given for 3 months. Outcomes were recorded by a blinded assessor. The primary endpoint was a decrease in headache frequency, headache intensity, and Headache Impact Test (HIT)-6 score. Secondary outcomes included change in Migraine Disability Assessment (MIDAS) score, pill count, and proportion of headache free patients.
Between April 2017 and August 2018, 160 patients with episodic migraine were randomly assigned to medical and yoga groups. A total of 114 patients completed the trial. Baseline measures were comparable except for a higher mean headache frequency in the yoga group. Compared to medical therapy, the yoga group showed a significant mean delta value reduction in headache frequency (delta difference 3.53 [95% confidence interval 2.52-4.54]; < 0.0001), headache intensity (1.31 [0.60-2.01]; = 0.0004), HIT score (8.0 [4.78-11.22]; < 0.0001), MIDAS score (7.85 [4.98-10.97]; < 0.0001), and pill count (2.28 [1.06-3.51]; < 0.0003).
Yoga as an add-on therapy in migraine is superior to medical therapy alone. It may be useful to integrate a cost-effective and safe intervention like yoga into the management of migraine.
CTRI/2017/03/008041.
This study provides Class III evidence that for patients with episodic migraine, yoga as adjuvant to medical therapy improves headache frequency, intensity, impact, and disability.
评估瑜伽作为辅助常规医学管理对偏头痛患者临床结局的有效性。
CONTAIN 是一项在印度新德里的一家三级学术医院进行的前瞻性、随机、开放标签优效性试验,采用盲终点评估。入组患者年龄 18-50 岁,诊断为发作性偏头痛,随机分为医学组和瑜伽组(1:1)。随机化采用可变大小和隐藏的计算机生成块。预设的瑜伽干预持续 3 个月。由盲法评估者记录结果。主要终点是头痛频率、头痛强度和头痛影响测试(HIT)-6 评分的降低。次要结局包括偏头痛残疾评估(MIDAS)评分、用药数量和无头痛患者比例的变化。
2017 年 4 月至 2018 年 8 月,共纳入 160 例发作性偏头痛患者,随机分为医学组和瑜伽组。共有 114 例患者完成了试验。基线测量结果除了瑜伽组的平均头痛频率较高外,其他指标均无差异。与医学治疗相比,瑜伽组头痛频率的平均差值显著降低(差值差异 3.53 [95%置信区间 2.52-4.54];<0.0001),头痛强度(1.31 [0.60-2.01];=0.0004),HIT 评分(8.0 [4.78-11.22];<0.0001),MIDAS 评分(7.85 [4.98-10.97];<0.0001)和用药数量(2.28 [1.06-3.51];<0.0001)。
瑜伽作为偏头痛的辅助治疗优于单纯医学治疗。将瑜伽等具有成本效益和安全性的干预措施纳入偏头痛的管理可能是有益的。
CTRI/2017/03/008041。
本研究提供了 III 级证据,表明对于发作性偏头痛患者,瑜伽作为医学治疗的辅助手段可改善头痛频率、强度、影响和残疾。